Psychosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

 Psychosis Market Outlook

Thelansis’s “Psychosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Psychosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Psychosis Overview

Psychosis is a mental disorder characterized by a disconnect from reality, evident through a decline in daily functioning and a breakdown of personality manifested as disturbances in emotions, thoughts (like delusions), perceptions (such as hallucinations), and behavior. The primary symptoms of psychosis include:

• Hallucinations: These involve perceiving things that aren’t present, such as hearing, seeing, or even feeling, smelling, or tasting things that have no physical existence. Hearing voices is a common form of hallucination.
• Delusions: These are false beliefs that, upon rational examination, are untrue. Sometimes, the cause of psychosis can be linked to specific mental health disorders, including:
• Schizophrenia leads to various psychological symptoms, including hallucinations and delusions.
• Bipolar disorder: A condition affecting mood, characterized by alternating episodes of depression (lows) and mania (highs).
• Severe depression: In some cases, severe depression can also trigger symptoms of psychosis.

Additionally, trauma, stress, physical ailments like Parkinson’s disease or brain tumors, as well as substance abuse (drugs or alcohol) can all act as triggers for psychosis. Nonetheless, a combination of genetic, biological, environmental, and psychological elements is believed to play a role. Managing psychosis involves a combination of approaches, including:

1. Antipsychotic medication: These drugs help alleviate the symptoms of psychosis.
2. Psychological therapies: Cognitive Behavioral Therapy (CBT), a one-on-one talking therapy, has shown effectiveness in assisting individuals with schizophrenia. Family therapy, where applicable, has been found to reduce the necessity for hospitalization in people with psychosis.
3. Social support: Addressing social needs like education, employment, and housing.

Individuals with a history of psychosis are more likely to struggle with substance abuse issues or alcohol misuse.

 

Geography coverage:

G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)

Insights driven by robust research, including:

• In-depth interviews with leading KOLs and payers
• Physician surveys
• RWE analysis for claims and EHR datasets
• Secondary research (e.g., peer-reviewed journal articles, third-party research databases)

Deliverables format and updates*:

• Detailed Report (PDF)
• Market Forecast Model (MS Excel-based automated dashboard)
• Epidemiology (MS Excel; interactive tool)
• Executive Insights (PowerPoint presentation)
• Others: regular updates, customizations, consultant support

*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.

Salient features of Market Forecast model:

• 10-year market forecast (2024–2034)
• Bottom-up patient-based market forecasts validated through the top-down sales methodology
• Covers clinically and commercially-relevant patient populations/ line of therapies
• Annualized drug-level sales and patient share projections
• Utilizes our proprietary Epilansis and Analog tool (e.g., drug uptake and erosion) datasets and conjoint analysis approach
• Detailed methodology/sources & assumptions
• Graphical and tabular outputs
• Users can customize the model based on requirements

Key business questions answered:

• How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)?
• How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments?
• What is the 10-year market outlook for sales and patient share?
• Which events will have the greatest impact on the market’s trajectory?
• What insights do interviewed experts provide on current and emerging treatments?
• Which pipeline products show the most promise, and what is their potential for launch and future positioning?
• What are the key unmet needs and KOL expectations for target profiles?
• What key regulatory and payer requirements must be met to secure drug approval and favorable market access?
• and more…

Read more: Psychosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034